mapracorat (BOL-303242-X) / Bayer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mapracorat (BOL-303242-X) / Bayer
NCT03399526: 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Completed
1
24
Europe
Mapracorat (ZK 245186, BAY 86-5319), Prednicarbate 0.25% ointment, Clobetasol 0.05% ointment, Calcipotriene 0.005% ointment, Calcipotriene 0.005%/Betamethasone dipropionate 0.05% ointment
Bayer
Psoriasis
05/13
05/13
NCT01736462: Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days

Completed
1
61
US
Mapracorat
Bausch & Lomb Incorporated
Corneal Endothelial Cell Changes
07/13
07/13

Download Options